These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


206 related items for PubMed ID: 29803931

  • 1. Long noncoding RNA TP73-AS1 promotes non-small cell lung cancer progression by competitively sponging miR-449a/EZH2.
    Zhang L, Fang F, He X.
    Biomed Pharmacother; 2018 Aug; 104():705-711. PubMed ID: 29803931
    [Abstract] [Full Text] [Related]

  • 2. E2F1-Induced Overexpression of Long Noncoding RNA SBF2-AS1 Promotes Non-Small-Cell Lung Cancer Metastasis Through Regulating miR-362-3p/GRB2 Axis.
    Wang A, Wang J.
    DNA Cell Biol; 2020 Jul; 39(7):1290-1298. PubMed ID: 32364763
    [Abstract] [Full Text] [Related]

  • 3. Upregulated long non-coding RNA AGAP2-AS1 represses LATS2 and KLF2 expression through interacting with EZH2 and LSD1 in non-small-cell lung cancer cells.
    Li W, Sun M, Zang C, Ma P, He J, Zhang M, Huang Z, Ding Y, Shu Y.
    Cell Death Dis; 2016 May 19; 7(5):e2225. PubMed ID: 27195672
    [Abstract] [Full Text] [Related]

  • 4. lncRNA ZEB2-AS1 Aggravates Progression of Non-Small Cell Lung Carcinoma via Suppressing PTEN Level.
    Chen X, Wang K.
    Med Sci Monit; 2019 Nov 07; 25():8363-8370. PubMed ID: 31695021
    [Abstract] [Full Text] [Related]

  • 5. LncRNA NR2F2-AS1 promotes tumourigenesis through modulating BMI1 expression by targeting miR-320b in non-small cell lung cancer.
    Zhang S, Zhang X, Sun Q, Zhuang C, Li G, Sun L, Wang H.
    J Cell Mol Med; 2019 Mar 07; 23(3):2001-2011. PubMed ID: 30592135
    [Abstract] [Full Text] [Related]

  • 6. LncRNA TP73-AS1 is upregulated in non-small cell lung cancer and predicts poor survival.
    Zhu D, Zhou J, Liu Y, Du L, Zheng Z, Qian X.
    Gene; 2019 Aug 20; 710():98-102. PubMed ID: 31129247
    [Abstract] [Full Text] [Related]

  • 7. Long non-coding RNA ZNFX1-AS1 promotes the tumor progression and metastasis of colorectal cancer by acting as a competing endogenous RNA of miR-144 to regulate EZH2 expression.
    Shi L, Hong X, Ba L, He X, Xiong Y, Ding Q, Yang S, Peng G.
    Cell Death Dis; 2019 Feb 15; 10(3):150. PubMed ID: 30770796
    [Abstract] [Full Text] [Related]

  • 8. Long noncoding RNA AFAP1-AS1 predicts a poor prognosis and regulates non-small cell lung cancer cell proliferation by epigenetically repressing p21 expression.
    Yin D, Lu X, Su J, He X, De W, Yang J, Li W, Han L, Zhang E.
    Mol Cancer; 2018 May 24; 17(1):92. PubMed ID: 29793547
    [Abstract] [Full Text] [Related]

  • 9. Long noncoding RNA SNHG7 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition in non-small cell lung cancer by regulating miR-449a/TGIF2 axis.
    Pang L, Cheng Y, Zou S, Song J.
    Thorac Cancer; 2020 Feb 24; 11(2):264-276. PubMed ID: 31793741
    [Abstract] [Full Text] [Related]

  • 10. Long non-coding RNA PSMA3-AS1 promotes malignant phenotypes of esophageal cancer by modulating the miR-101/EZH2 axis as a ceRNA.
    Qiu BQ, Lin XH, Ye XD, Huang W, Pei X, Xiong D, Long X, Zhu SQ, Lu F, Lin K, Zhang XQ, Xu JJ, Sheng LL, Zhang XM, Zhang PF, Wu YB.
    Aging (Albany NY); 2020 Jan 31; 12(2):1843-1856. PubMed ID: 32005028
    [Abstract] [Full Text] [Related]

  • 11. Long Noncoding RNA FGD5-AS1 Knockdown Decrease Viability, Migration, and Invasion of Non-Small Cell Lung Cancer (NSCLC) Cells by Regulating the MicroRNA-944/MACC1 Axis.
    Lv J, Li Q, Ma R, Wang Z, Yu Y, Liu H, Miao Y, Jiang S.
    Technol Cancer Res Treat; 2021 Jan 31; 20():1533033821990090. PubMed ID: 33550920
    [Abstract] [Full Text] [Related]

  • 12. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
    Zhang DY, Sun QC, Zou XJ, Song Y, Li WW, Guo ZQ, Liu SS, Liu L, Wu DH.
    J Exp Clin Cancer Res; 2020 Oct 29; 39(1):229. PubMed ID: 33121524
    [Abstract] [Full Text] [Related]

  • 13. Long non-coding RNA HNF1A-AS1 promotes cell proliferation and invasion via regulating miR-17-5p in non-small cell lung cancer.
    Zhang G, An X, Zhao H, Zhang Q, Zhao H.
    Biomed Pharmacother; 2018 Feb 29; 98():594-599. PubMed ID: 29289833
    [Abstract] [Full Text] [Related]

  • 14. STAT1-induced upregulation of lncRNA KTN1-AS1 predicts poor prognosis and facilitates non-small cell lung cancer progression via miR-23b/DEPDC1 axis.
    Liu C, Li X, Hao Y, Wang F, Cheng Z, Geng H, Geng D.
    Aging (Albany NY); 2020 May 12; 12(9):8680-8701. PubMed ID: 32396871
    [Abstract] [Full Text] [Related]

  • 15. Regulation of tumorigenesis and ferroptosis in non-small cell lung cancer by a novel BBOX1-AS1/miR-326/PROM2 axis.
    An J, Shi J, Yang C, Luo J, Li Y, Ren J, Lv Y, Zhang Y.
    Mol Cell Biochem; 2024 Aug 12; 479(8):2143-2155. PubMed ID: 37639200
    [Abstract] [Full Text] [Related]

  • 16. lncRNA HNF1A-AS1 modulates non-small cell lung cancer progression by targeting miR-149-5p/Cdk6.
    Liu L, Chen Y, Li Q, Duan P.
    J Cell Biochem; 2019 Nov 12; 120(11):18736-18750. PubMed ID: 31243821
    [Abstract] [Full Text] [Related]

  • 17. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.
    Huang Y, Ni R, Wang J, Liu Y.
    Biomed Pharmacother; 2019 Jan 12; 109():1851-1859. PubMed ID: 30551440
    [Abstract] [Full Text] [Related]

  • 18. Long non-coding RNA FGD5-AS1 promotes non-small cell lung cancer cell proliferation through sponging hsa-miR-107 to up-regulate FGFRL1.
    Fan Y, Li H, Yu Z, Dong W, Cui X, Ma J, Li S.
    Biosci Rep; 2020 Jan 31; 40(1):. PubMed ID: 31919528
    [Abstract] [Full Text] [Related]

  • 19. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W, Zhang Y, Xia S.
    Thorac Cancer; 2020 Mar 31; 11(3):549-560. PubMed ID: 31923353
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA-4465 suppresses tumor proliferation and metastasis in non-small cell lung cancer by directly targeting the oncogene EZH2.
    Sun J, Tian X, Lu SQ, Hu HB.
    Biomed Pharmacother; 2017 Dec 31; 96():1358-1362. PubMed ID: 29169732
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.